ストックスクリーナーアプリを入手
18.64
7.31%
1.27
アフターアワーズ：
18.88
0.24
+1.29%
前日終値:
$17.37
開ける：
$17.85
24時間の取引高:
5.10M
Relative Volume:
1.87
時価総額：
$2.39B
収益：
$745.97M
当期純損益:
$-99.21M
株価収益率:
-24.12
EPS:
-0.7729
ネットキャッシュフロー:
$-5.09M
1週間 パフォーマンス:
+12.76%
1か月 パフォーマンス:
+41.86%
6か月 パフォーマンス:
+89.62%
1年 パフォーマンス:
+163.28%
1日の値動き範囲:
$17.85
$19.76
1週間の範囲:
$16.21
$19.76
52週間の値動き範囲:
$6.945
$19.76
Neogenomics Inc Stock (NEO) Company Profile
Compare NEO vs TMO, DHR, NTRA, A, IQV
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NEO
Neogenomics Inc
|
18.64 | 2.12B | 745.97M | -99.21M | -5.09M | -0.7729 |
TMO
Thermo Fisher Scientific Inc
|
630.70 | 232.03B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
215.68 | 151.78B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
338.70 | 46.82B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
157.69 | 44.14B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
262.38 | 42.15B | 16.63B | 1.39B | 2.12B | 8.0674 |
Neogenomics Inc Stock (NEO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-30 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-07-29 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2025-05-15 | 開始されました | Guggenheim | Neutral |
| 2025-04-30 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-01-13 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2024-12-10 | 開始されました | Jefferies | Buy |
| 2024-05-01 | 再開されました | Craig Hallum | Buy |
| 2023-12-29 | 繰り返されました | BTIG Research | Buy |
| 2023-08-21 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2023-05-16 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-05-09 | アップグレード | BTIG Research | Neutral → Buy |
| 2023-02-24 | アップグレード | The Benchmark Company | Hold → Buy |
| 2023-02-01 | アップグレード | Needham | Hold → Buy |
| 2022-08-26 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-08-22 | ダウングレード | Needham | Buy → Hold |
| 2022-06-03 | 開始されました | Piper Sandler | Overweight |
| 2022-03-29 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-03-29 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2022-01-18 | 再開されました | Stephens | Overweight |
| 2021-12-16 | 開始されました | Cowen | Outperform |
| 2021-11-05 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-14 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2021-06-03 | 開始されました | Goldman | Buy |
| 2021-02-25 | 再開されました | Needham | Buy |
| 2021-02-25 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2021-01-28 | 開始されました | Truist | Buy |
| 2020-12-11 | 再開されました | BTIG Research | Buy |
| 2020-10-28 | 繰り返されました | Needham | Buy |
| 2020-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2020-08-28 | 開始されました | Guggenheim | Buy |
| 2020-07-29 | 繰り返されました | Needham | Buy |
| 2020-06-25 | 開始されました | BofA/Merrill | Buy |
| 2020-04-21 | 再開されました | Stephens | Overweight |
| 2020-03-02 | 再開されました | Craig Hallum | Buy |
| 2020-02-28 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2020-01-23 | ダウングレード | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-30 | 繰り返されました | Needham | Buy |
| 2019-05-01 | 繰り返されました | Needham | Buy |
| 2019-03-29 | 繰り返されました | Needham | Buy |
| 2019-01-03 | 開始されました | Needham | Buy |
| 2018-10-24 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2018-08-21 | 開始されました | Leerink Partners | Outperform |
| 2018-05-02 | ダウングレード | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-11 | ダウングレード | BTIG Research | Buy → Neutral |
| 2017-08-24 | 開始されました | Gabelli & Co | Buy |
| 2016-12-15 | 開始されました | Cantor Fitzgerald | Overweight |
すべてを表示
Neogenomics Inc (NEO) 最新ニュース
NeoGenomics (NASDAQ:NEO) Healthcare Innovation Gains Attention - Kalkine Media
NeoGenomics (NASDAQ:NEO) Reaches New 12-Month HighHere's Why - MarketBeat
Neogenomics stock hits 52-week high at 16.93 USD - Investing.com
Neogenomics stock hits 52-week high at 16.93 USD By Investing.com - Investing.com India
NeoGenomics, Inc. Revenue Breakdown – NASDAQ:NEO - TradingView
NeoGenomics (NEO) Advances 1.44% to $16.17 as Buyers Hold Above Key SupportPercent Above MA - vinanet.vn
NeoGenomics (NASDAQ:NEO) Enters A New Growth Spotlight - Kalkine Media
NeoGenomics, Inc. (NASDAQ:NEO) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Neogenomics Stock Price Forecast. Should You Buy NEO? - StockInvest.us
NeoGenomics (NEO) stake tops 8% for First Light’s Mathew Arens - Stock Titan
NeoGenomics | SCHEDULE 13G/A: Others - Moomoo
California State Teachers Retirement System Raises Position in NeoGenomics, Inc. $NEO - MarketBeat
NeoGenomics, Inc. (NEO) Stock Forecasts - Yahoo Finance
NeoGenomics Senior VP & Chief Accounting Officer Gregory Aunan Sells 80% Of Holding - simplywall.st
GC To Depart Cancer Diagnostic Co. NeoGenomics - Law360
Renaissance Technologies LLC Acquires New Shares in NeoGenomics, Inc. $NEO - MarketBeat
Form 8K NeoGenomics Inc For: 11 August By Investing.com - Investing.com India
Technical Reactions to NEO Trends in Macro Strategies - Stock Traders Daily
NeoGenomics announces planned departure of General Counsel Alicia Olivo - Investing.com
NeoGenomics (NEO) Slips to $16.50 as Biotech Diagnostic Stocks Face Cautious TradingVWAP Deviation - Vinanet
NeoGenomics (NASDAQ:NEO) Sets New 1-Year HighShould You Buy? - MarketBeat
MFG Wealth Management Inc. Takes Position in NeoGenomics, Inc. $NEO - marketbeat.com
NeoGenomics, Inc. (NEO) Stock forecasts - Yahoo Finance Australia
Has NeoGenomics (NEO) Priced In Its Turnaround Following Q2 Profitability? - simplywall.st
NeoGenomics (NEO) Is Up 8.4% After Q2 Profit Return And Raised 2026 Outlook – Has The Bull Case Changed? - finance.yahoo.com
Neogenomics stock hits 52-week high at 16.46 USD By Investing.com - Investing.com UK
Neogenomics stock hits 52-week high at 16.46 USD - Investing.com
NEOUSD (NEOUSD) Stock News Today - TradingKey
NeoGenomics Appoints Carolyn Starrett to its Board of Directors - The National Law Review
NeoGenomics, Inc. $NEO Stock Position Raised by Sei Investments Co. - MarketBeat
Dimensional Fund Advisors LP Buys 225,588 Shares of NeoGenomics, Inc. $NEO - MarketBeat
NeoGenomics, Inc. Revenue Breakdown – BX:NG9 - TradingView
NeoGenomics Laboratories Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Neogenomics Insider Sold Shares Worth $321,400, According to a Recent SEC Filing - marketscreener.com
NeoGenomics (NEO) accounting chief sells 20,000 shares, keeps equity awards - Stock Titan
BlackRock, Inc. Expands NeoGenomics Inc (NEO) Stake with Strategic Share Acquisition - GuruFocus
NeoGenomics Shareholder Action Reminder - TMX Newsfile
NeoGenomics, Inc. $NEO Shares Sold by Glenmede Trust Co. NA - MarketBeat
NeoGenomics, Inc. (NEO) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
NeoGenomics (NASDAQ:NEO) Reaches New 1-Year HighHere's What Happened - MarketBeat
NEO (NEO) holder to sell 20,000 shares after restricted stock vests - Stock Titan
NEO5107997 Bond Profile — Key Metrics - TradingView
Segall Bryant & Hamill LLC Lowers Holdings in NeoGenomics, Inc. $NEO - MarketBeat
NeoGenomics (NEO) Following Q2 Profit And Raised Outlook, Is Fair Value Already Priced In? - Yahoo Finance
Is NeoGenomics Inc (NEO) a Bargain After 3.7% Drop? GF Value Says Undervalued - GuruFocus
Trading the Move, Not the Narrative: (NEO) Edition - Stock Traders Daily
Planned insider share sale for NEO (NASDAQ: NEO) under Rule 144 - Stock Titan
Update: NeoGenomics Shares Rise After Q2 Beat - Moomoo
A Quick Look at Today's Ratings for NeoGenomics(NEO.US), With a Forecast Between $19 to $19 - moomoo.com
Neogenomics stock hits 52-week high at 15.61 USD By Investing.com - Investing.com Nigeria
Needham Raises Price Target on NeoGenomics to $19 From $15, Keeps Buy Rating - marketscreener.com
Neogenomics Inc (NEO) 財務データ
収益
当期純利益
現金流量
EPS
0.24%
1.51%
大文字化:
|
ボリューム (24 時間):